Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Objective We provide evidence‐based recommendations regarding the treatment of
interstitial lung disease (ILD) in adults with systemic autoimmune rheumatic diseases …

Interstitial lung disease (ILD) is a frequent complication of rheumatoid arthritis (RA) that is
associated with a significant increase in mortality. Several risk factors for the development of …

Interstitial lung disease (ILD) is a serious complication of rheumatoid arthritis (RA)
contributing to significantly increased morbidity and mortality. Other respiratory …

Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and
clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases …

Background Studies suggest a harmful pharmacogenomic interaction exists between short
leukocyte telomere length (LTL) and immunosuppressants in idiopathic pulmonary fibrosis …

Background Primary Sjogren's Syndrome (pSS) is a classic, immune-mediated, condition of
unknown aetiology characterized by focal lymphocytic infiltration of exocrine glands [1] …

Interstitial lung disease (ILD) and pulmonary fibrosis comprise a wide array of inflammatory
and fibrotic lung diseases which are often confusing to general medicine and pulmonary …

Lung ailments in rheumatic diseases present unique challenges for diagnosis and
management and are a source of significant morbidity and mortality for patients. Unlike the …